08:00 , Dec 7, 2009 |  BC Week In Review  |  Clinical News

CellaVision DM1200 regulatory update

FDA granted market clearance for CellaVision's CellaVision DM1200, a diagnostic test to provide a preliminary differential count of peripheral blood. The company plans to launch the product in the U.S. next quarter. CellaVision DM1200, which...